Literature DB >> 10198725

Tyrosine kinase inhibitors in chronic myeloid leukemia.

C L Sawyers1, B Druker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198725

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN: 1081-4442


× No keyword cloud information.
  6 in total

1.  Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells.

Authors:  Bing Z Carter; Duncan H Mak; Wendy D Schober; Maria Cabreira-Hansen; Miloslav Beran; Teresa McQueen; Wenjing Chen; Michael Andreeff
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

2.  Three-way complex variant translocation involving short arm chromosome (1;9;22)(p36;q34;q11) in a chronic myeloid leukemia patient.

Authors:  Muhammad Asif; Abrar Hussain; Arif Malik; Mahmood Rasool
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

3.  Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis.

Authors:  Jack L Arbiser; Baskaran Govindarajan; Xianhe Bai; Hiroaki Onda; Andrius Kazlauskas; So Dug Lim; Mahul B Amin; Lena Claesson-Welsh
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

4.  Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.

Authors:  Bassam Francis Matti; Alaa Fadhil Alwan; Alaa Fadhil Alwan
Journal:  Turk J Haematol       Date:  2013-12-05       Impact factor: 1.831

5.  Targeting of the Alox12-12-HETE in Blast Crisis Chronic Myeloid Leukemia Inhibits Leukemia Stem/Progenitor Cell Function.

Authors:  Si Gao; Jialin Hu; Yong Li
Journal:  Cancer Manag Res       Date:  2020-12-03       Impact factor: 3.989

6.  Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody.

Authors:  Tomoyuki Tanaka; Jemima Thomas; Rob Van Montfort; Ami Miller; Terry Rabbitts
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.